Keywords: biogen, avonex, most, cost-effective, inf-beta, drugmaker, idec

Biogen's Avonex: most cost-effective INF-beta

Article | 23 April 2007

Print This

US drugmaker Biogen Idec says that one-year data presented at the Academy of Managed Care Pharmacy's 2007 annual meeting show that ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in